These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4048973)

  • 1. The rationale behind intraperitoneal chemotherapy in gastrointestinal malignancies.
    Speyer JL
    Semin Oncol; 1985 Sep; 12(3 Suppl 4):23-8. PubMed ID: 4048973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraperitoneal 5-fluorouracil infusion for treatment of both peritoneal and liver micrometastases.
    Archer S; Gray B
    Surgery; 1990 Sep; 108(3):502-7. PubMed ID: 2396194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged treatment schedules with intraperitoneal 5-fluorouracil diminish the local-regional nature of drug distribution.
    Sugarbaker PH; Klecker RW; Gianola FJ; Speyer JL
    Am J Clin Oncol; 1986 Feb; 9(1):1-7. PubMed ID: 3953487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of intraperitoneal infusion 5-fluorouracil and mitomycin-C.
    Gyves J
    Semin Oncol; 1985 Sep; 12(3 Suppl 4):29-32. PubMed ID: 3931225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans.
    Speyer JL; Sugarbaker PH; Collins JM; Dedrick RL; Klecker RW; Myers CE
    Cancer Res; 1981 May; 41(5):1916-22. PubMed ID: 7214359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum, urine and peritoneal fluid levels of 5-FU following intraperitoneal administration.
    Campora E; Esposito M; Civalleri D; Gogioso L; Decian F; Balletto N; Falcone A; Nobile MT; Parodi B; Cafaggi S
    Anticancer Res; 1987; 7(4B):829-32. PubMed ID: 3674768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective, randomized trial of intravenous versus intraperitoneal 5-fluorouracil in patients with advanced primary colon or rectal cancer.
    Sugarbaker PH; Gianola FJ; Speyer JC; Wesley R; Barofsky I; Meyers CE
    Surgery; 1985 Sep; 98(3):414-22. PubMed ID: 3898450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A feasibility, pharmacokinetic and frequency-escalation trial of intraperitoneal chemotherapy in high risk gastrointestinal tract cancer.
    Seymour MT; Trigonis I; Finan PJ; Halstead F; Dunham R; Wilson G; Farrugia D; Chester JD; King J; Brown CB; Slevin ML; Joel SP
    Eur J Surg Oncol; 2008 Apr; 34(4):403-9. PubMed ID: 17604939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of carrier solutions on pharmacokinetics of intraperitoneal chemotherapy.
    Pestieau SR; Schnake KJ; Stuart OA; Sugarbaker PH
    Cancer Chemother Pharmacol; 2001 Mar; 47(3):269-76. PubMed ID: 11320672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective randomized trial of intravenous v intraperitoneal 5-FU in patients with advanced primary colon or rectal cancer.
    Sugarbaker PH; Gianola FJ; Speyer JL; Wesley R; Barofsky I; Myers CE
    Semin Oncol; 1985 Sep; 12(3 Suppl 4):101-11. PubMed ID: 3901269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraperitoneal chemotherapy in the management of colon cancer.
    Markman M
    Semin Oncol; 1999 Oct; 26(5):536-9. PubMed ID: 10528901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental pharmacokinetic studies of carboplatin intraperitoneal chemotherapy].
    Wang J; Chen JQ
    Zhonghua Zhong Liu Za Zhi; 1994 May; 16(3):196-8. PubMed ID: 7956698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental study on intraperitoneal and intravenous administration of anti-tumor agents for liver metastasis].
    Maruyama M; Nagahama T; Ebuchi M; Irie T; Yoshida T; Kure M
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1782-5. PubMed ID: 10560394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constant intraperitoneal 5-fluorouracil infusion through a totally implanted system.
    Gyves JW; Ensminger WD; Stetson P; Niederhuber JE; Meyer M; Walker S; Janis MA; Gilbertson S
    Clin Pharmacol Ther; 1984 Jan; 35(1):83-9. PubMed ID: 6690173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer: speculations on the role of intraperitoneal therapy.
    Muggia FM
    Semin Oncol; 1985 Sep; 12(3 Suppl 4):112-5. PubMed ID: 4048969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraperitoneal chemotherapy with melphalan.
    Howell SB; Pfeifle CE; Olshen RA
    Ann Intern Med; 1984 Jul; 101(1):14-8. PubMed ID: 6732077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetic comparison of intraperitoneal and intravenous 5-Fu administration].
    Qing SH
    Zhonghua Zhong Liu Za Zhi; 1991 Sep; 13(5):340-2. PubMed ID: 1782844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of carcinomatosis and intraperitoneal 5-fluorouracil on peritoneal blood flow modulated by vasopressin in the rat as measured with the 133Xe-clearance technique.
    Oman M; Tölli J; Naredi P; Hafström LO
    Cancer Chemother Pharmacol; 2004 Sep; 54(3):213-8. PubMed ID: 15138707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical response and plasma levels of 5-fluorouracil in patients with colonic cancer treated by drug infusion.
    Hillcoat BL; McCulloch PB; Figueredo AT; Ehsan MH; Rosenfeld JM
    Br J Cancer; 1978 Dec; 38(6):719-24. PubMed ID: 743489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraperitoneal chemotherapy as treatment for ovarian carcinoma and gastrointestinal malignancies: the Memorial Sloan-Kettering Cancer Center experience).
    Markman M; Reichman B; Hakes T; Hoskins W; Rubin S; Jones W; Lewis JL
    Acta Med Austriaca; 1989; 16(3-4):65-7. PubMed ID: 2609915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.